Disease | breast cancer |
Phenotype | C0011570|depression |
Sentences | 55 |
PubMedID- 21054923 | Sexual abuse in childhood and postoperative depression in women with breast cancer who opt for immediate reconstruction after mastectomy. |
PubMedID- 23725190 | Prevalence of depression in breast cancer survivors: a systematic review of observational studies. |
PubMedID- 24077731 | According to the prisma guidelines, we conducted a systematic review of randomized, controlled clinical trials and open label prospective studies on antidepressants effects on depression in women with breast cancer up to january 14, 2013. |
PubMedID- 20385344 | Several psychotherapeutic modalities offer relief of the symptoms and syndromes of depression in breast cancer. |
PubMedID- 22639749 | In some studies, it has been stated that breast cancer metastasis is associated with depression and overall quality of life, and it has also been reported that the recurrence of breast cancer strongly lowered the quality of life of patients, and even their guardians.6,7 this appears to be due to a fear of additional metastasis as well as the burden of additional treatments after metastasis. |
PubMedID- 26445699 | 1996), whereas a helplessness/hopelessness stress-coping style is associated with depression in patients with breast cancer (schou et al. |
PubMedID- 25954147 | (2013) investigated fatigue and depression symptoms in patients with breast cancer. |
PubMedID- 19458878 | Materials and methods: this was a prospective study of anxiety and depression in breast cancer patients. |
PubMedID- 26453348 | These results suggest that ipt is a promising treatment for depression in women with breast cancer. |
PubMedID- 20602189 | A randomized trial of bupropion vs. other antidepressants, both at standard and lower doses (similar to those used for hot flash management), would provide valuable information and offer options for breast cancer patients with both depression and sexual dysfunction. |
PubMedID- 25761086 | Trajectories of distress, anxiety, and depression among women with breast cancer: looking beyond the mean. |
PubMedID- 24362868 | Treatment of depression in patients with breast cancer: a critical review. |
PubMedID- 24007891 | This case highlights the incidence of depression in persons with breast cancer, examines the controversy of tamoxifen-induced depression, and evaluates antidepressant considerations regarding potentially efficacy-reducing cytochrome p450 2d6 drug interactions with tamoxifen. |
PubMedID- 23646866 | Methods: sixty-two breast cancer patients diagnosed with major depression were randomly assigned to gcbt group (n = 31) or a waiting list control group provided with an educational booklet (n = 31). |
PubMedID- 23041586 | Conclusions: exercise intervention improved fatigue, depression, and qol in patients with breast cancer receiving adjuvant therapy. |
PubMedID- 23865135 | Objective: to investigate the prevalence of depression in women with breast cancer and relate it to their health-related quality of life. |
PubMedID- 26064177 | Moreover, we found that the anxiety, depression, and stress levels of breast cancer patients could be reduced after a single tlp session. |
PubMedID- 24337537 | Some evidence suggests that a decrease in depression in patients with metastatic breast cancer is associated with lower mortality [42]. |
PubMedID- 26009671 | Aim: to compare the effects of yoga program with supportive therapy on self-reported symptoms of depression in breast cancer patients undergoing conventional treatment. |
PubMedID- 26508964 | The individual effects of bdnf promoter methylation percentages on depression in patients with breast cancer at the two evaluations were tested using multivariate logistic regression models after adjustment for those sociodemographic and clinical characteristics that were significantly associated with depression at 1 week or 1 year after breast surgery (p<0.05). |
PubMedID- 26035180 | breast cancer patients with a depression diagnosis also had lower mortality (or=0.69, 95% ci: 0.52-0.89) compared with those without a depression diagnosis, but there was no significant difference in mortality among those with and without anxiety diagnoses. |
PubMedID- 22888085 | depression in breast cancer patients and survivors is related to negative disease outcomes and worse quality of life. |
PubMedID- 23512358 | Predictors of depression in breast cancer patients treated with radiation: role of prior chemotherapy and nuclear factor kappa b. |
PubMedID- 25960844 | Effectiveness of group training based on acceptance and commitment therapy on anxiety and depression of women with breast cancer. |
PubMedID- 23217093 | Methods/design: eligible breast cancer patients with comorbid depression are assigned to short-term psychodynamic psychotherapy (up to 20 + 5 sessions) or to treatment as usual (augmented by recommendation for counseling center and physician information). |
PubMedID- 25684491 | Associations among physical activity, comorbidity, functional capacity, peripheral muscle strength and depression in breast cancer survivors. |
PubMedID- 23604452 | Icf, quality of life, and depression in breast cancer: perceived disability in disease-free women 6 months after mastectomy. |
PubMedID- 20142325 | The prevalence of depression in women with early breast cancer is roughly twice that of the general female population and is particularly high around the time of diagnosis.39 in our study, 30% of women who started tamoxifen treatment also received antidepressants, and paroxetine was the most commonly used ssri. |
PubMedID- 23788906 | The association of breast cancer with anxiety and depression has been supported in previous studies [3–6]. |
PubMedID- 24817896 | Arts therapies for anxiety, depression, and quality of life in breast cancer patients: a systematic review and meta-analysis. |
PubMedID- 24243809 | Eysenck personality questionnaire revised psychoticism predicts motivational-somatic symptoms of depression in breast cancer survivors. |
PubMedID- 22699176 | Further studies are needed to identify the effect on emotions such as anxiety and depression for women with breast cancer with above average levels of anxiety and depression. |
PubMedID- 25287728 | Methods: seventy-seven breast cancer patients with comorbid depression were evaluated with the hamilton depression rating scale (hamd), the clinical global impression-severity of illness (cgi-s) for depression, and the functional assessment of cancer therapy-breast (fact-b). |
PubMedID- 20814770 | Estimation of anxiety and depression in patients with early stage breast cancer before and after radiation therapy. |
PubMedID- 26516588 | Now established agents such as trastuzumab (herceptin), a monoclonal antibody targeted against mutant forms of the her2/neu receptor licensed for use against some forms of breast cancer, are associated with cardiac depression and an increase in adverse outcomes when combined with other anticancer agents with known cardiotoxicity risks (seidman et al. |
PubMedID- 23731173 | Exercise programmes are safe and effective on quality of life and depression in breast cancer patients whose treatments are complete. |
PubMedID- 24347520 | Patients and methods: in a multicenter prospective trial, 157 breast cancer patients with comorbid depression were randomized to either individual stpp (intervention group, n=78) or 'treatment as usual' (control group, tau, n=79). |
PubMedID- 25780852 | Evaluation of symptoms of anxiety and depression in women with breast cancer after breast amputation or conservation treated with adjuvant chemotherapy. |
PubMedID- 25921125 | Background: whether depression causes increased risk of the development of breast cancer has long been debated. |
PubMedID- 21462281 | Conclusion: our study suggests a high rate of associated depression among patients with breast cancer in our environment. |
PubMedID- 25377647 | Here, we review the prevalence and treatment of anxiety and depression among patients with breast cancer. |
PubMedID- 25788991 | In a cohort study investigating breast cancer outcomes in patients with depression, only 51% of the study group (breast cancer patients with depression) accepted and commenced chemotherapy, compared with 92% of the control group (breast cancer patients without depression) (4). |
PubMedID- 21567239 | Sleep duration among breast cancer survivors correlates with fatigue, depression, and health-related quality of life (hrqol); however, this has not been studied longitudinally. |
PubMedID- 25674442 | The use of selected serotonin reuptake inhibitors (ssri’s), anti-depressives used to treat both hot flashes and depression in women with breast cancer, has recently been the focus of controversy. |
PubMedID- 25201115 | Cancer-related fatigue and depression in breast cancer patients postchemotherapy: different associations with optimism and stress appraisals. |
PubMedID- 23124416 | Influence of age, performance status, cancer activity, and il-6 on anxiety and depression in patients with metastatic breast cancer. |
PubMedID- 22409643 | Anxiety and depression in breast cancer survivors of different sexual orientations. |
PubMedID- 23967823 | However, due to a few of studies (the number is less than or equal to 3) separately reporting the or for depression and anxiety in patients with breast cancer, lung cancer, liver cancer, the subgroup comparison of depression and anxiety in different types of cancer patients were not analyzed. |
PubMedID- 25111433 | Although several outcome studies have explored the utility of psychotherapy for breast cancer patients with subsyndromal depression symptoms, only a few clinical trials have explored the efficacy of behavior therapy for patients with well-diagnosed mdd. |
PubMedID- 25543421 | [efficacy on depression in breast cancer treated with acupuncture and auricular acupressure]. |
Page: 1 2